Skip to main content
Research
  • Blog
  • Publications
  • Careers
  • Focus areas
  • Semiconductors
  • Artificial Intelligence
  • Quantum Computing
  • Hybrid Cloud
  • About
  • Overview
  • Labs
  • People
  • Semiconductors
  • Artificial Intelligence
  • Quantum Computing
  • Hybrid Cloud
  • Overview
  • Labs
  • People
IBM logo
Research
  • Focus areas
    • Semiconductors
    • Artificial Intelligence
    • Quantum Computing
    • Hybrid Cloud
  • Blog
  • Publications
  • Careers
  • About
    • Overview
    • Labs
    • People
Tetrahedron Letters
Paper
01 Jan 1974

The azobenzene radical cation, an intermediate during diazonium reactions

View publication

Abstract

No abstract available.

Related

Paper

Chinese Public's engagement in preventive and intervening health behaviors during the early breakout of COVID-19: Cross-sectional study

Zhaomeng Niu, Tingting Wang, et al.

JMIR

Paper

Dreaming during the Covid-19 pandemic: Computational assessment of dream reports reveals mental suffering related to fear of contagion

Natália Bezerra Mota, Janaina Weissheimer, et al.

PLoS ONE

Paper

Lies, Gosh Darn Lies, and not enough good statistics: why epidemic model parameter estimation fails

Daniel Platt, Laxmi Parida, et al.

Scientific Reports

Paper

The lipogenic regulator srebp2 induces transferrin in circulating melanoma cells and suppresses ferroptosis

Xin Hong, Whijae Roh, et al.

Cancer Discovery

View all publications
  1. Home
  2. ↳ Publications

Date

01 Jan 1974

Publication

Tetrahedron Letters

Authors

  • Joachim Bargon
  • Karl-Gerhard Seifert
IBM-affiliated at time of publication

Topics

  • Healthcare

Resources

  • Publication

Share

IBM Logo
  • Focus areas

    • Semiconductors
    • Artificial Intelligence
    • Quantum Computing
    • Hybrid Cloud
  • Quick links

    • About
    • Publications
    • Blog
    • Events
  • Work with us

    • Careers
    • Contact Research
  • Directories

    • Topics
    • People
    • Projects
  • Follow us

    • Newsletter
    • X
    • LinkedIn
    • YouTube
  • Contact IBM
  • Privacy
  • Terms of use
  • Accessibility